DL-01 formic is a cleavable drug-linker conjugate designed for the synthesis of antibody-drug conjugates (ADCs). It is used in research to develop ADCs for targeted cancer therapy, with applications in both in vitro cytotoxicity assays and in vivo efficacy studies in preclinical models.